Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Treace Medical Concepts Inc

TMCI
Current price
7.63 USD -0.26 USD (-3.30%)
Last closed 7.92 USD
ISIN US89455T1097
Sector Healthcare
Industry Medical Devices
Exchange NASDAQ
Capitalization 500 868 672 USD
Yield for 12 month -4.03 %
1Y
3Y
5Y
10Y
15Y
TMCI
21.11.2021 - 28.11.2021

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida. Address: 100 Palmetto Park Place, Ponte Vedra, FL, United States, 32081

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

7.38 USD

P/E ratio

Dividend Yield

Current Year

+187 118 000 USD

Last Year

+141 838 000 USD

Current Quarter

+45 086 000 USD

Last Quarter

+44 455 000 USD

Current Year

+151 937 000 USD

Last Year

+114 315 000 USD

Current Quarter

+36 132 000 USD

Last Quarter

+35 674 000 USD

Key Figures TMCI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -54 627 000 USD
Operating Margin TTM -33.57 %
PE Ratio
Return On Assets TTM -17.13 %
PEG Ratio
Return On Equity TTM -50.69 %
Wall Street Target Price 7.38 USD
Revenue TTM 202 860 992 USD
Book Value 1.69 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 10.6 %
Dividend Yield
Gross Profit TTM 114 315 000 USD
Earnings per share -0.99 USD
Diluted Eps TTM -0.99 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY
Profit Margin -30.33 %

Dividend Analytics TMCI

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History TMCI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation TMCI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 2.4065
Price Sales TTM 2.469
Enterprise Value EBITDA -40.9453
Price Book MRQ 4.7745

Financials TMCI

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators TMCI

For 52 weeks

3.92 USD 15.98 USD
50 Day MA 5.45 USD
Shares Short Prior Month 4 928 031
200 Day MA 8.38 USD
Short Ratio 9.25
Shares Short 4 908 353
Short Percent 10.1 %